(2020). Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain.
Chicago Style (17th ed.) CitationHumanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting the Spike Receptor Binding Domain. 2020.
MLA (8th ed.) CitationHumanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting the Spike Receptor Binding Domain. 2020.
Warning: These citations may not always be 100% accurate.